Interestingly, SNX10 knockout mice exhibited significantly ameliorated ethanol-induced hepatic steatosis and injury via inhibition of CTSA maturation, LAMA2A stabilization and, thus, CMA activation 9. Here, SNX10 is linked to fatty liver disease.